Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Salmon Calcitonin in Knee Osteoarthritis
2005-004145-34Phase 3Completed
- Sponsor
- Nordic Bioscience
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Oral salmon calcitonin with Placebo (2 arms). Primary endpoints: Joint space width in index knee, Pain in index knee and 1 more. Started Sep 2005; status: completed.
02
Drugs
calcitonin salmon
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2005-004145-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004145-34.